Table 2.
Characteristics of the six patients with sickle cell disease and SARS-CoV-2 infection.
Age (years) | Gender | SCD genotype | Chief complaints | SARS-Cov2 PCR | Chest X-ray | Hb (g/dL) | WBC (x10^9/L) | CRP (mg/L) | Maximum oxygenation support | Management | Discharge day |
---|---|---|---|---|---|---|---|---|---|---|---|
23 | Male | HbSS | Asymptomatic: tested positive on return from travel | Positive | Normal | 17.1 | 3.28 | N/A | None | Observation alone | 10 |
40 | Male | HbSS | Fever, myalgia, cough and diarrhea | Positive | Infiltrates | 7.4 | 13.73 | 137 | Nasal cannula 2 L O2 | Blood transfusion, antibiotics | 10 |
52 | Male | HbSS | Asymptomatic: tested positive on return from travel | Positive | Normal | 10.2 | 6.77 | 7.3 | None | Observation alone | 12 |
25 | Male | HbSS | Asymptomatic: tested positive on contact tracing | Positive | Normal | 12.8 | 3.71 | 4.5 | None | Observation alone | 8 |
21 | Female | HbSS | Fever, loss of smell and taste | Positive | Normal | 13.8 | 4.61 | 4.22 | None | Supportive and IVF | 8 |
24 | Female | HbSS | Fever and myalgia | Positive | Normal | 8.5 | 11.63 | 1.48 | None | Antibiotics, supportive care | 9 |